Profile for Spain Patent: 2857523
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Spain Patent: 2857523
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jul 22, 2035 | Novartis Pharm | TABRECTA | capmatinib hydrochloride |
| ⤷ Start Trial | Jul 22, 2035 | Novartis Pharm | TABRECTA | capmatinib hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
